![]()
|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Papers In Press, published online ahead of print April 27, 2004
Oncological Sciences, University of Utah, Salt Lake City, Utah 84112-5550
Corresponding Author: frank.fitzpatrick{at}hci.utah.edu
The selenoenzyme thioredoxin reductase regulates redox-sensitive proteins involved in inflammation and carcinogenesis, including ribonucleotide reductase, p53, NF
J. Biol. Chem, 10.1074/jbc.M313939200
Submitted on December 19, 2003
Revised on April 27, 2004
Accepted on April 27, 2004
Conditional expression of 15-lipoxygenase-1 inhibits the selenoenzyme thioredoxin reductase: Modulation of selenoproteins by lipoxygenase enzymes
B, and others. Little is known about endogenous cellular factors that modulate thioredoxin reductase activity. Here we report that several metabolites of 15-lipoxygenase-1 inhibit purified thioredoxin reductase in vitro. 15(S)-Hydroperoxy-5, 8, 11-cis -13-trans- eicosatetraenoic acid, a metastable hydroperoxide generated by 15-lipoxygenase-1, and 4-hydroxy-2-nonenal, its non-enzymatic rearrangement product inhibit thioredoxin reductase with IC50 = 13 ± 1.5
M and 1 ± 0.2
M, respectively. Endogenously generated metabolites of 15-lipoxygenase-1 also inhibit thioredoxin reductase in HEK 293 cells that harbor a 15-LOX-1 gene under the control of an inducible promoter complex. Conditional, highly selective induction of 15-lipoxygenase-1 caused an inhibition of ribonucleotide reductase activity, cell cycle arrest in G1, impairment of anchorage-independent growth, and accumulation of the pro-apoptotic protein BAX. All of these responses are consistent with inhibition of thioredoxin reductase via 15-lipoxygenase-1 overexpression. In contrast, metabolites of 5-lipoxygenase were poor inhibitors of isolated thioredoxin reductase, and the overexpression of 5-lipoxygenase did not inhibit thioredoxin reductase or cause a G1 cell cycle arrest. The influences of 15-lipoxygenase-1 on inflammation, cell growth and survival may be attributable, in part, to inhibition of thioredoxin reductase and several redox-sensitive processes subordinate to thioredoxin reductase.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
P. Cordray, K. Doyle, K. Edes, P. J. Moos, and F. A. Fitzpatrick Oxidation of 2-Cys-peroxiredoxins by Arachidonic Acid Peroxide Metabolites of Lipoxygenases and Cyclooxygenase-2 J. Biol. Chem., November 9, 2007; 282(45): 32623 - 32629. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. B. Cassidy, K. Edes, C. C. Nelson, K. Parsawar, F.A. Fitzpatrick, and P. J. Moos Thioredoxin reductase is required for the inactivation of tumor suppressor p53 and for apoptosis induced by endogenous electrophiles Carcinogenesis, December 1, 2006; 27(12): 2538 - 2549. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Torosyan, A. Dobi, S. Naga, K. Mezhevaya, M. Glasman, C. Norris, G. Jiang, G. Mueller, H. Pollard, and M. Srivastava Distinct Effects of Annexin A7 and p53 on Arachidonate Lipoxygenation in Prostate Cancer Cells Involve 5-Lipoxygenase Transcription Cancer Res., October 1, 2006; 66(19): 9609 - 9616. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Lippman and J. J. Lee Reducing the "Risk" of Chemoprevention: Defining and Targeting High Risk--2005 AACR Cancer Research and Prevention Foundation Award Lecture. Cancer Res., March 15, 2006; 66(6): 2893 - 2903. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Shureiqi, Y. Wu, D. Chen, X. L. Yang, B. Guan, J. S. Morris, P. Yang, R. A. Newman, R. Broaddus, S. R. Hamilton, et al. The Critical Role of 15-Lipoxygenase-1 in Colorectal Epithelial Cell Terminal Differentiation and Tumorigenesis Cancer Res., December 15, 2005; 65(24): 11486 - 11492. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. R. Hirsch and S. M. Lippman Advances in the Biology of Lung Cancer Chemoprevention J. Clin. Oncol., May 10, 2005; 23(14): 3186 - 3197. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Lippman and B. Levin Cancer Prevention: Strong Science and Real Medicine J. Clin. Oncol., January 10, 2005; 23(2): 249 - 253. [Full Text] [PDF] |
||||
![]() |
A. J. Duffield-Lillico, I. Shureiqi, and S. M. Lippman Can Selenium Prevent Colorectal Cancer? A Signpost From Epidemiology J Natl Cancer Inst, November 17, 2004; 96(22): 1645 - 1647. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |